In this week's episode of The Crypto Craze Cheddar Anchors Brad Smith and Baker Machado explain the biggest trends in the market. This week the value of Bitcoin plunged to just 50 percent of its 2017 peak. Several other cryptocurrencies saw double digit losses compared to their highs last year. Many citing the potential crackdown on regulation in South Korea and China as a trigger of this volatility. Venture firm Full Tilt Capital is making the move to only invest in tokenized securities. The firm's Managing Partner Anthony Pompliano explains the investment opportunity he sees in this space. "There's going to be a bunch of scams, there's going to be a lot of people that are going to get caught up in the tightening of regulation, but we are also going to get a lot of sustainable technologies that come out of this," says Pompliano. He says he sees the infrastructure, miners, exchanges, and the wallets as being the true winners in this evolving space. Browser plug-in "Trive" is using the power of blockchain to combat fake new. The company's founder and CEO David Mondrus explains how he is leveraging this technology, and his outlook on the cryptocurrency market. "We have fact-checkers on the net," says Mondrus. Trive crowdsources the verification of news through blockchain technology.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More